{
"id":"mk19_bb_gm_s22",
"subspecialtyId":"gm",
"title":"Opioid Use Disorder",
"jsonContent":{
"type":"section",
"id":"mk19_bb_gm_s22",
"title":{
"__html":"Opioid Use Disorder"
},
"titleNode":{
"type":"section-title",
"hlId":"9b22c9",
"children":[
"Opioid Use Disorder"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_gm_s22_0",
"children":[
{
"type":"p",
"hlId":"b527d7",
"children":[
"Prescription opioids are a major cause of morbidity and mortality. The risk for overdose is increased with higher doses (>50 morphine mg equivalents/d) and concurrent benzodiazepine prescription."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_gm_s22_1",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"a028a2",
"children":[
"Most patients with opioid use disorder will require psychosocial support and medication-assisted treatment (buprenorphine-naloxone, buprenorphine, ",
{
"type":"abbreviation",
"title":"intramuscular",
"children":[
"IM"
]
},
" naltrexone). Intranasal naloxone is an important adjunctive therapy in opioid use disorder. Friends and family members may also receive prescriptions and training in naloxone use."
]
}
]
}
]
},
"tablesContent":{
}
}